Philippe Duchateau
Chief Tech/Sci/R&D Officer chez CELLECTIS S.A.
Fortune : 103 811 $ au 31/03/2024
Provenance du réseau au premier degré de Philippe Duchateau
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 46 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philippe Duchateau via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| VIATAR CTC SOLUTIONS INC. | Medical Specialties | Director/Board Member | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SOCIÉTÉ GÉNÉRALE | Major Banks | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
| VERGNET S.A. | Electrical Products | Director of Finance/CFO | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member President Director/Board Member Director/Board Member General Counsel Chief Executive Officer | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CARMAT | Medical Specialties | Chairman Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
npower
 npower Miscellaneous Commercial ServicesCommercial Services Npower is a national nonprofit organization that aims to move people from poverty to the middle class by providing free, six-month training programs to youth from underserved communities and military-connected individuals in a range of tech skills. The non-profit company is based in Brooklyn, NY. The program offers industry-recognized certifications and places students in paid internships with corporate and nonprofit organizations. The CEO of the company is Bertina Ceccarelli. | Miscellaneous Commercial Services | Director/Board Member | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Messier Maris & Associés SCA provides financial consulting and investment advisory services. The company was founded by Jean-Marie Messier and Erik Maris in 2010 and is headquartered in Paris, France. | Investment Managers | Founder Director/Board Member | |
Fournier Group, Inc.
 Fournier Group, Inc. Multi-Line InsuranceFinance Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021. | Multi-Line Insurance | Corporate Officer/Principal | |
| LYSOGENE | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Shango NV
 Shango NV Financial ConglomeratesFinance Shango NV is a well-established cannabis brand that offers a full range of award-winning products, including flower, extracts, concentrates, and cannabis-infused edibles. The private company is based in Nevada, USA, and has subsidiaries in other states. The Belgian company has operations in multiple locations and has full-service recreational and medical cannabis dispensaries in various cities. Shango is building several facilities for cultivation, extraction, and production. The company also operates a state-of-the-art cannabis distribution center in southern Nevada. Shango is committed to cannabis education and advocates for the safe and responsible use of cannabis products. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NEOMA Business School | College/University | Undergraduate Degree Masters Business Admin | |
Hougou Développement SA
 Hougou Développement SA Financial ConglomeratesFinance Hougou Développement SA is an investment holding private company based in Ixelles, Belgium. The Belgian company's main function is to hold investments in other companies. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Kotys SA | Director/Board Member Director/Board Member | ||
| RELAY THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Hougou Finance SA
 Hougou Finance SA Financial ConglomeratesFinance Hougou Finance SA is an investment holding Belgian company founded in 2016. The private company is based in Ixelles, Belgium. | Financial Conglomerates | Chairman Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Chairman Chairman | |
MicroPEP Technologies SAS
 MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALTAMIRA THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
| Intercell Austria AG | Director/Board Member | ||
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman Chairman | |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Standing Ovation SAS
 Standing Ovation SAS Food: Meat/Fish/DairyConsumer Non-Durables Part of UNIBEL SA, Standing Ovation SAS is a French company that specializes in animal-free dairy cheese. The private company is based in Paris, France. Standing Ovation is focused on providing new solutions to environmental and ethical challenges. The company was founded in 2020 by Romain Chayot, Frédéric Pâques. Frédéric Pâques has been the CEO since 2020. Standing Ovation was acquired by Bel SA on November 15, 2022. | Food: Meat/Fish/Dairy | Chief Executive Officer President | |
| CELLNOVO | Medical Specialties | Director of Finance/CFO | |
| GLOBAL BIOENERGIES | Chemicals: Specialty | Chief Operating Officer Corporate Officer/Principal |
Statistiques
Internationale
| France | 22 |
| Etats-Unis | 17 |
| Suède | 4 |
| Belgique | 4 |
| Suisse | 3 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 7 |
| Process Industries | 3 |
Opérationnelle
| Director/Board Member | 174 |
| Corporate Officer/Principal | 79 |
| Chairman | 42 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 36 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alain Munoz | 38 |
| Pierre Bastid | 29 |
| Jean-Pierre Garnier | 28 |
| Mathieu Simon | 22 |
| Laurent Arthaud | 21 |
| Jean-Marie Messier | 18 |
| David Sourdive | 16 |
| Marc Le Bozec | 16 |
| Elsy Boglioli Hofman | 14 |
| Rainer Boehm | 12 |
| Alain Godard | 12 |
| Herve Hoppenot | 11 |
| Annick Schwebig | 11 |
| Donald Bergstrom | 9 |
| Pierre Schwich | 8 |
- Bourse
- Insiders
- Philippe Duchateau
- Connexions Sociétés
